STAT Plus: Startup Spotlight: This Cambridge biotech snagged a deal with Roche without ever making a pitch
ALEX HOGAN/STAT
GO Therapeutics announced Tuesday it had licensed antibodies for a particular cancer target to Roche. Rather than pitching themselves, Roche came to them.
No hay comentarios:
Publicar un comentario